{"id":"W3010760372","doi":"10.1200/jco.2006.24.18_suppl.15523","title":"A phase I/II trial of weekly docetaxel and cisplatin for locoregionally recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN)","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Docetaxel; Medicine; Neutropenia; Tolerability; Cisplatin; Internal medicine; Febrile neutropenia; Oncology; Chemotherapy; Phases of clinical research; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001601335,0.001668232,0.002115914,0.0004357755,0.000491499,0.0007872281,0.001079355,0.001158093,0.005808934],"category_scores_gemma":[0.0008869223,0.0006928767,0.0009503007,0.0004754947,0.0009832161,0.0006074726,0.0003467189,0.002801163,0.001300551],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009362275,"about_ca_system_score_gemma":0.001757712,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001418329,"about_ca_topic_score_gemma":0.003623828,"domain_scores_codex":[0.9996289,0.0001709344,0.00002783498,0.00007175488,0.00003801181,0.00006254348],"domain_scores_gemma":[0.9993142,0.00008310306,0.0001110795,0.00004447041,0.00003235859,0.0004148434],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7724588,0.1010986,0.005332461,0.001167387,0.001127864,0.00046055,0.0003940544,0.001709918,0.03246083,0.0002820433,0.006255725,0.07725178],"study_design_scores_gemma":[0.7628844,0.2283366,0.004923374,0.00002825384,0.0002079271,0.0001839885,0.00003101503,0.0005087702,0.001154469,0.00008403756,0.00164015,0.00001710813],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9898171,0.001507657,0.0003766018,0.0003459875,0.000124456,0.005584634,0.000797611,0.00008046196,0.001365427],"genre_scores_gemma":[0.98027,0.001711795,0.003058186,0.001182384,0.0001857697,0.007027219,0.002485392,0.00002735046,0.004051782],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005808934,"threshold_uncertainty_score":0.01943278,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1335168061579326,"score_gpt":0.4633993990421669,"score_spread":0.3298825928842343,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}